Inhibition of NGLY1 has been shown to adversely impact cancer cell viability, however the ddVenus reporter could be inhibited through alterations to its translation, translocation, or degradation through another means (Tomlin et al. 2017; Zolekar et al. 2018). The gene discussed is NGLY1; the disease is cancer.